Allurion, stomach balloon, GLP-1 compresses weight loss data from combo

[ad_1]

Losing weight loss

Via matdesign24 / iSyTy Images

Microcap Allurion Technologies (NYSE:Channel( Increased by ~ 31% On Thursday after sending preliminary information about weight loss over weight related to the stomach balloon with Novo Nordisk’sVery cite) GLP-1 semaglutide.

A study of 52 individuals who are already loaded

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *